Nordic Capital is to acquires a majority share in IntegriChain, a provider of pharmaceutical technology, data, consulting, and outsourcing solutions designed to improve how life sciences products reach customers.
IntegriChain delivers ICyte, a fully integrated platform for commercialisation and market access, helping manufacturers bring their science to market while ensuring patients have affordable, timely, and sustainable access to therapy.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Nordic Capital is acquiring the majority stake from Accel-KKR, a global software private equity firm, which first invested in IntegriChain in 2016.
Terms of the transaction, which is expected to complete before the end of the year subject to customary closing conditions, have not been disclosed.
Source: PrivateEquityWire
Can’t stop reading? Read more
Carlyle takes over UK retailer The Very Group, ending Barclay family era
Carlyle takes over UK retailer The Very Group, ending Barclay family era Carlyle Group has taken...
Permira takes JTC private in £2.3bn deal backed by Canada Pension Plan Investment Board
Permira takes JTC private in £2.3bn deal backed by Canada Pension Plan Investment Board Permira...
Fund Friday: Top fundraising news in private equity
Fund Friday: Top fundraising news in private equity Aquilius Investment Partners, a...